Local view for "http://purl.org/linkedpolitics/eu/plenary/2005-10-26-Speech-3-268"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2005-10-26"^^xsd:date2
dcterms:Is Part Of	lp_eu:Council Question Time2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20051026.18.3-268"2
lpv:hasSubsequent	lp_eu:2005-10-26-Speech-3-2692
lpv:speaker	lp:Manuel dos Santos2
lpv:spokenAs	vice-president; European Parliament (2005-04-12--2007-01-15)3 substitute; Delegation to the ACP-EU Joint Parliamentary Assembly (2004-09-15--2009-07-13)3 substitute; ITRE (2004-07-21--2007-01-14)3 vice-president; Parliament's Bureau (2005-04-12--2007-01-15)3 member; ECON (2004-07-21--2007-01-14)3 member; PES (2004-07-20--2009-07-13)3 unknown; Partido Socialista (2004-07-20--2009-07-13)3 member; Delegation for relations with the Maghreb countries and the Arab Maghreb Union (including Libya) (2004-10-28--2007-03-13)3
lpv:translated text	"Question No 13 by Richard Corbett () In considering the health section of the 7th Framework Programme for Research and Development, will the Council consider the relevance of different types of health issues to the Lisbon Agenda? Is the Council aware that respiratory diseases cost European health services more than €102 billion and are the most frequent conditions requiring general practice consultations and emergency hospital admissions, presenting an enormous burden in terms of working days lost? Does the Council agree that research in this area is likely to provide both health and economic benefits and therefore make a major contribution to the Lisbon strategy?"@en1
lpv:unclassifiedMetadata	"President. –"1 "Subject: Respiratory diseases and the Lisbon Agenda"1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph